Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia

Published:2012-04-09 Issue:10 Volume:26 Page:2245-2253
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Palmi C,Vendramini E,Silvestri D,Longinotti G,Frison D,Cario G,Shochat C,Stanulla M,Rossi V,Di Meglio A M,Villa T,Giarin E,Fazio G,Leszl A,Schrappe M,Basso G,Biondi A,Izraeli S,Conter V,Valsecchi M G,Cazzaniga G,te Kronnie G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012101.pdf

Reference20 articles.

1. Pui CH, Carroll WL, Meshinchi S, Arceci RJ . Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011; 29: 551–565.

2. Waanders E, van der Velden VH, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, de Haas V et al. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia 2011; 25: 254–258.

3. Ottmann OG, Pfeifer H . Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Hematol Am Soc Hematol Educ Program 2009; 2009: 371–381.

4. Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. J Clin Oncol 2009; 27: 5175–5181.

5. Izraeli S . Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside? Br J Haematol 2010; 151: 119–131.

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review;Annals of Hematology;2024-08-21

2. CRLF2 and IKZF1 abnormalities in childhood hematological malignancies other than B-cell Acute Lymphoblastic Leukemia;Leukemia & Lymphoma;2024-07-21

3. The impact of comparative genomic hybridization/single‐nucleotide polymorphism microarray in risk stratification of pediatric acute lymphoblastic leukemia;Pediatric Blood & Cancer;2024-07-02

4. Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening;Heliyon;2024-07

5. The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis;Blood;2024-06-27